HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ilaria Cavazzana Selected Research

RNA Polymerase III

6/2022Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
1/2017Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.
7/2011Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
7/2010Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.
6/2009Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ilaria Cavazzana Research Topics

Disease

13Myositis (Idiopathic Inflammatory Myopathies)
10/2022 - 12/2010
11Systemic Scleroderma (Systemic Sclerosis)
06/2022 - 06/2009
8Interstitial Lung Diseases (Interstitial Lung Disease)
06/2022 - 11/2014
7Dermatomyositis (Dermatopolymyositis)
10/2022 - 07/2011
6Neoplasms (Cancer)
10/2022 - 07/2011
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 09/2009
6Autoimmune Diseases (Autoimmune Disease)
08/2015 - 09/2005
5COVID-19
01/2022 - 07/2020
5Rheumatoid Arthritis
09/2021 - 09/2014
5Arthritis (Polyarthritis)
11/2019 - 08/2015
4Polymyositis
02/2021 - 07/2011
4Antisynthetase syndrome
11/2019 - 08/2015
3Calcinosis
10/2022 - 04/2012
3Lupus Nephritis
10/2021 - 01/2021
3Connective Tissue Diseases (Connective Tissue Disease)
11/2018 - 07/2002
2Skin Manifestations
10/2022 - 11/2014
2digital ulcers
06/2022 - 01/2022
2Gastric Antral Vascular Ectasia (Watermelon Stomach)
06/2022 - 07/2010
2Deglutition Disorders (Dysphagia)
03/2021 - 02/2017
2Necrosis
03/2021 - 04/2015
2Rheumatic Diseases (Rheumatism)
01/2017 - 07/2011
2Ankylosing Spondylitis
04/2015 - 09/2014
2Inflammation (Inflammations)
11/2014 - 12/2010
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
03/2011 - 03/2007
1Inclusion Body Myositis
10/2022
1Rupture
06/2022
1Sjogren's Syndrome (Sjogren Syndrome)
01/2022
1Raynaud Disease (Raynaud's Disease)
01/2022
1Cough
02/2021
1Dyspnea (Shortness of Breath)
02/2021
1Silicosis
01/2021
1Proteinuria
01/2021
1Respiratory Insufficiency (Respiratory Failure)
07/2020
1Lymphopenia (Lymphocytopenia)
07/2020
1Pneumonia (Pneumonitis)
07/2020
1Localized Scleroderma (Morphea)
08/2018
1Hodgkin Disease (Hodgkin's Disease)
02/2017
1Muscle Weakness
02/2017
1Malnutrition (Nutritional Deficiencies)
02/2016
1Macular Edema
04/2015
1Cryoglobulinemia
03/2015
1Melanoma (Melanoma, Malignant)
11/2014
1Aseptic Meningitis
09/2014
1Peripheral Nervous System Diseases (PNS Diseases)
04/2013
1Rubella (German Measles)
04/2013

Drug/Important Bio-Agent (IBA)

28AntibodiesIBA
10/2022 - 07/2002
19AutoantibodiesIBA
10/2022 - 10/2010
5Ligases (Synthetase)IBA
10/2022 - 01/2016
5Proteins (Proteins, Gene)FDA Link
10/2022 - 02/2017
5RNA Polymerase IIIIBA
06/2022 - 06/2009
3Biomarkers (Surrogate Marker)IBA
06/2022 - 07/2011
3Immunoglobulin G (IgG)IBA
01/2021 - 09/2005
3AntigensIBA
08/2018 - 10/2011
3Phospholipids (Phosphatides)FDA LinkGeneric
03/2011 - 03/2007
2RNA (Ribonucleic Acid)IBA
10/2022 - 02/2017
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 01/2021
2Antinuclear AntibodiesIBA
01/2022 - 08/2018
2Antirheumatic Agents (DMARD)IBA
01/2022 - 01/2021
2Abatacept (Orencia)FDA Link
09/2021 - 01/2021
2Intravenous Immunoglobulins (IVIG)FDA Link
03/2021 - 02/2017
2Biological ProductsIBA
01/2021 - 04/2015
2Rheumatoid FactorIBA
08/2018 - 01/2018
2Pharmaceutical PreparationsIBA
03/2017 - 04/2015
2Cell ExtractsIBA
01/2016 - 07/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2014 - 09/2014
2SS-A antibodiesIBA
03/2011 - 09/2005
2Complement System Proteins (Complement)IBA
12/2010 - 09/2009
2Antiphospholipid AntibodiesIBA
07/2010 - 09/2005
1Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2022
1SiliconesIBA
06/2022
1IgA receptor (protein B)IBA
01/2022
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2022
1SteroidsIBA
01/2022
1VaccinesIBA
12/2021
1Rituximab (Mabthera)FDA Link
12/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2021
1GlucocorticoidsIBA
12/2021
1EnzymesIBA
03/2021
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
03/2021
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2021
1Anti-Idiotypic AntibodiesIBA
01/2021
1Monoclonal AntibodiesIBA
07/2020
1Fibrinogen (Factor I)FDA Link
07/2020
1Interleukin-6 (Interleukin 6)IBA
07/2020
1C-Reactive ProteinIBA
07/2020
1Ferritins (Ferritin)IBA
07/2020
1tocilizumab (atlizumab)FDA Link
07/2020
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2019
1Transfer RNA (tRNA)IBA
11/2019
15'-Nucleotidase (5' Nucleotidase)IBA
11/2018
1Poly UIBA
11/2018
1Histones (Histone)IBA
08/2018
1Immunoglobulin M (IgM)IBA
01/2018
1Mi-2 antibodiesIBA
02/2017
1Prealbumin (Transthyretin)IBA
02/2016
1InterferonsIBA
04/2015
1Thalidomide (Thalomid)FDA Link
03/2015

Therapy/Procedure

5Therapeutics
09/2020 - 04/2012
1Breast Implants (Breast Implant)
06/2022
1Intravenous Administration
07/2020